Found 22 matching trials
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases
Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .
PHASE3Dapagliflozin reduces the risk of de novo heart failure (HF) in diabetics a...
Location
Hospital Clinico Universitario Virgen de la Arrixaca
Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy
PHASE4In this open clinical trial, 30 subjects with inadequately controlled T2D a...
Location
University of Pisa
Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
PHASE4This is a single-center, non-randomzied pilot study investigating a combina...
Location
Northwestern University
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
PHASE2Justification: Studies in recent years have shown that suffering an episode...
Location
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
PHASE2The development of ascites is a landmark event in the natural history of ci...
Location
Dept of Hepatology, PGIMER
A Real World Experience of Dapagliflozin in Type 2 Diabetes
N/AType 2 diabetes mellitus (T2DM) is creating a health pandemic globally. Man...
Location
Multiple Locations
Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes
PHASE1Dapagliflozin has a unique mechanism of action that does not directly affec...
Location
Kinder - und Jugendkrankenhaus AUF DER BULT
Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes
PHASE2A Phase 2 study Comparing the effects on glucose control of MEDI0382 in com...
Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction
PHASE3Microcirculatory dysfunction is a key driver of organ failure and mortality...
Location
Hôpital Civil, Service de médecine intensive et réanimation, Hôpitaux Universitaires de Strasbourg